Communiqués

13/11 RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S. GL
07/11 RAMM Pharma Corp. Provides Additional Disclosure in Connection with its Upcoming Special Meeting of Shareholders GL
22/10/25 RAMM Pharma Corp. Provides Update on Canada post strike and mailing of the Company´s meeting materials GL
31/05/25 Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp. AQ
21/01/25 RAMM Pharma Corp. Provides Update on Canapar GL
11/12/24 RAMM Pharma Corp. Provides Update on Litigation GL
21/05/24 RAMM Pharma Corp. Provides Update on Litigation GL
28/03/24 RAMM Pharma Corp. Announces Corporate Update GL
19/03/24 RAMM Pharma Corp. Announces Corporate Update GL
14/12/23 RAMM Pharma Corp. Announces Corporate Update GL
30/11/23 RAMM Pharma Corp. Announces Corporate Update GL
30/11/23 RAMM Pharma Corp. Announces Corporate Update AQ
18/11/23 RAMM Pharma Corp. Announces Corporate Update. GL
18/11/23 RAMM Pharma Corp. Announces Corporate Update. AQ
11/10/23 RAMM Pharma Corp. Announces Corporate Update GL
28/09/23 Canadian Investment Regulatory Organization Trade Resumption - RAMM AQ
28/09/23 RAMM Pharma Corp. Announces Clarification of its Corporate Update of September 12th GL
12/09/23 IIROC Trading Halt - RAMM AQ
12/09/23 RAMM Pharma Corp. Announces Corporate Update GL
05/09/23 RAMM Pharma Corp. Announces Non-Brokered Private Placement and Intention to Commence Normal Course Issuer Bid GL
13/02/23 Ramm Pharma Announces Application for Management Cease Trade Order GL
13/02/23 Ramm Pharma Announces Application for Management Cease Trade Order AQ
09/12/22 RAMM Pharma Corp. Announces Appointment of new Interim-Chief Financial Officer GL
09/12/22 RAMM Pharma Corp. Announces Appointment of new Interim-Chief Financial Officer AQ
06/09/22 RAMM Pharma Corp. Acquires Leading European Hemp Manufacturer HemPoland GL
Aucun résultat pour cette recherche